We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Cholesterol Crystals Suggest Looming Heart Attack

By HospiMedica International staff writers
Posted on 28 Aug 2017
Image: Cholesterol crystals arising from within the artery wall, causing tearing and damage (Photo courtesy of MSU).
Image: Cholesterol crystals arising from within the artery wall, causing tearing and damage (Photo courtesy of MSU).
Cholesterol crystals that pierce the arterial plaque and intima trigger local and systemic inflammation that can lead to a myocardial infarction (MI), according to a new study.

Researchers at Michigan State University (MSU; East Lansing, USA) conducted a study involving 240 emergency room patients who died of MI in order to examine the role of cholesterol in the crystallized state on atherosclerosis and plaque rupture, and its contribution to acute MI and stroke. To visualize the cholesterol crystals, the researchers processed the tissue without ethanol. They found that cholesterol expands when crystallizing from the liquid to the solid state, which is the presumed cause of plaque rupture by the sharp-tipped crystals growing out of the plaque’s necrotic core.

The researchers found that in patients who died of MI, culprit coronary lesions had extensive cholesterol crystals perforating the fibrous cap and intima, while atherosclerotic patients who died of other causes did not have such perforating crystals. They also found that cholesterol crystals traveling downstream from the plaque rupture site can scrape the endothelium and promote vasospasm, and that cholesterol crystals lodging into the muscle can trigger an inflammation with necrosis, independent of circulatory compromise or ischemia. The study was published on May 1, 2017, in Cardiovascular Innovations and Applications.

“In previous studies, we showed that when cholesterol goes from a liquid to a solid, or crystal state, it expands in volume like ice and water. This expansion inside the wall of the artery can tear it and block blood flow causing a heart attack or stroke,” said senior author George Abela, MD, chief cardiologist at MSU. “Since cholesterol crystals form very early in the process of heart disease, with great potential to aggravate atherosclerosis, we can target new therapies by reducing cholesterol crystal deposits early on or use an inhibitor to block the inflammatory biomarker.”

Cholesterol is a modified steroid in the form of a lipid molecule, biosynthesized by all animal cells, and is an essential structural component comprising up to 30% of all cell membranes. Cholesterol also serves as a precursor for the biosynthesis of steroid hormones, bile acid, and vitamin D.

Related Links:
Michigan State University

Gold Member
CPAP Ventilator
Somnus DM18
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more